| IP issues outsourcing R&D
|
2009 |
Milbradt, Claudia |
| Key IP issues for life sciences companies doing business in China
|
2009 |
Lam, Cedric |
| Enforcing plant variety rights in Mexico
|
2009 |
Arceo, Abraham Diaz |
| Managing IP in a difficult economic environment
|
2009 |
Cronin, John |
| Business models, value chains and value propositions
|
2009 |
Arena, Christopher M. |
| Pharmaceutical patents in Italy : hot topics
|
2009 |
Santonocito, Federica |
| Key issues of pharmaceutical trademarks
|
2009 |
Viefhues, Martin |
| Standardising IP valuations : whether, what and how
|
2009 |
Sullivan, Patrick H. |
| Life sciences patent strategies in Europe
|
2009 |
Andersson, Inga-Lill |
| Understanding and unifying diverse IP strategy perspectives
|
2009 |
Cronin, John |
| False patent marking : a trap for the unwary patentee
|
2009 |
Vassallo, Edward E. |
| The long road to harmonisation
|
2008 |
Adams, Sara-Jayne |
| Increasing transparency in the IP transaction markets
|
2008 |
Henderson, Paul |
| Building a capital market for intangibles
|
2008 |
Jarboe, Kenan Patrick |
| Spinning out for success
|
2008 |
Socolof, Stephen J. |
| Just say no to a broad research use exemption in the US
|
2008 |
Haber, Stephen H. |
| Taking on the trolls
|
2008 |
Bittner, Peter |
| Reputation resilience
|
2008 |
Gerken, Peter J. |
| Breaking through the glass ceiling
|
2008 |
Adams, Sara-Jayne |
| Inside the IP markets of North Asia
|
2008 |
Desai, Sachin |
Tag hinzufügen